Xaira Therapeutics — Startup Profile

AI-powered discovery and development of life-changing medicines

HQ: San Francisco, CA | Founded: 2024 | Employees: Not publicly disclosed | Stage: Venture-backed growth company | Website: https://www.xaira.com

About

Xaira Therapeutics is an integrated biotechnology company using AI to learn the language of biology and discover and develop new medicines.

The Take

Xaira is one of the most heavily cdeveloper toolstalized AI-biotech launches, giving it room to pursue ambitious programs. The tradeoff is that large initial funding creates high expectations while biology, clinical trials, and therapeutic timelines remain inherently uncertain.

Key Metrics

• Founded: 2024
• Founders: Marc Tessier-Lavigne
• Latest signal: Xaira launches with more than $1B in committed capital
• Products: 3

Funding Rounds

• Round: More than $1B (2024-04) — Arch Venture Partners and Foresite Labs

Key People

• Marc Tessier-Lavigne

Key Competitors

• Incumbent platforms —
• Specialist startups —

Timeline Highlights

• 2024-04: Committed launch capital
• 2024: Founded

Recent News

• Xaira launches with more than $1B in committed capital (2024-04-24)

Similar Startups

• Aether Biomachines — Designing industrial proteins with computers and biology.
• Cresta — Enterprise AI platform for contact centers — real-time coaching for human agents plus AI virtual age
• Enveda Biosciences — Finding medicines in the chemistry of nature.
• Firecrawl — The web data API for AI agents — 1.5M+ users, now building Alexandria, the knowledge library that pa
• Poolside — Frontier model company for software engineering — GitHub CTO-built, now Nvidia's $7B bet on an open-

Browse: Home | Blog | About | All Startups A-Z | View full profile on StartupWiki